About DexCom
DexCom (NASDAQ:DXCM) is a company specializing in the development, manufacturing, and distribution of continuous glucose monitoring (CGM) systems for people with diabetes. These pioneering CGM systems are designed to help patients and healthcare professionals monitor and manage glucose levels in real-time, lending support towards more informed treatment decisions and better glycemic control. Aimed at enhancing the quality of life for individuals living with diabetes, DexCom is committed to advancing technology that can lead to more seamless and effective diabetes management. The company's projects include not only improving the accuracy and usability of its CGM devices but also integrating its technology with a variety of digital health platforms and devices to offer comprehensive diabetes management solutions. DexCom's objectives focus on innovation, accessibility, and continuing to meet the evolving needs of the diabetes community worldwide.
Snapshot
Operations
Products and/or services of DexCom
- Continuous Glucose Monitoring (CGM) Systems for diabetes management, offering real-time glucose readings and trends.
- The Dexcom G6 CGM, providing no-calibration glucose monitoring with a slim, water-resistant sensor.
- Dexcom CLARITY diabetes management software, offering insights and reporting for both patients and healthcare providers.
- Dexcom G7, the next-generation CGM system, designed for easier and more discreet diabetes management.
- Dexcom ONE, a simpler and more affordable CGM solution aimed at broader access to glucose monitoring.
- Integration solutions with insulin pumps and other digital health apps for cohesive diabetes management.
DexCom executive team
- Mr. Jacob Steven LeachPresident, CEO & Director
- Mr. Kevin Ronald SayerExecutive Chairman of the Board (Leave of Absence)
- Mr. Jereme M. Sylvain CPAExecutive VP, CFO & Chief Accounting Officer
- Mr. Michael Jon BrownExecutive VP & Chief Legal Officer
- Ms. Sadie M. SternExecutive VP & Chief Human Resources Officer
- Mr. Girish NaganathanExecutive VP & CTO
- Mr. Sean ChristensenVice President of Finance and Investor Relations
- Mr. Matthew DolanExecutive Vice President of Strategy & Corporate Development
- Mr. Donald M. AbbeyExecutive Vice President of Global Business Services, Regulatory, Medical & Clinical Affairs
- Mr. Jon ColemanExecutive VP & Chief Commercial Officer